Dreavent
Finance · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Kendall Sq, Cambridge, Massachusetts, ...Website
www.dreaventcapital.comRevenue
<$5 MillionIndustry
About Dreavent
Dreavent Capital is a Boston-based strategic investment firm specializing in biotech investments, focusing on funding innovative companies that contribute to future cures. The firm is launching the Dreavent Engine 2026 fund, aiming to invest in 5-6 companies annually with a target of $210 million by 2026. Dreavent employs a unique model that starts with confirmed pharmaceutical demand, ensuring that every investment has an engaged pharmaceutical partner before capital is deployed. With a team experienced in both venture capital and pharmaceutical relationships, Dreavent connects scientific ecosystems to Boston's biotech infrastructure, facilitating the development of globally competitive pharma assets.Explore more
Dreavent Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Dreavent
Compare insights from companies similar to Dreavent, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Dreavent Tech Stack
A closer look at the technologies used by Dreavent
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Dreavent
Sign Up For FreeTo access detailed company insights
Dreavent Capital is a Boston-based strategic investment firm specializing in biotech investments, focusing on funding innovative companies that contribute to future cures. The firm is launching the Dreavent Engine 2026 fund, aiming to invest in 5-6 companies annually with a target of $210 million by 2026. Dreavent employs a unique model that starts... Read More
